| Chronic Kidney Disease |
1 |
1 |
| Renal Failure |
0 |
0.75 |
| Acute Kidney Injury |
0 |
0.95 |
| Toxicology |
0 |
0.67 |
| Wound Management |
0 |
0.65 |
| Injury |
0 |
0.59 |
| Intravenous |
0 |
0.56 |
| Disaster Medicine |
0 |
0.55 |
| Thromboembolism |
0 |
0.51 |
| Pain Management |
0 |
0.46 |
| Contrast Medium |
0 |
0.45 |
| Electronic Health Record (EHR) and Healthcare Technology |
0 |
0.25 |
| Hospital Medicine |
0 |
0.21 |
| Revenue and Practice Management |
0 |
0.21 |
| Hospital |
0 |
0.19 |
| Patient Safety |
0 |
0.15 |
| Acute Mesenteric Ischemia |
0 |
0.14 |
| Clinical Research |
0 |
0.13 |
| Cardiovascular Imaging |
0 |
0.12 |
| Mesentric Ischemia |
0 |
0.11 |
| Renal Disease |
0 |
0.11 |
| Hemodialysis |
0 |
0.09 |
| Blood |
0 |
0.08 |
| Colorado |
0 |
0.08 |
| CT Scan |
0 |
0.08 |
| Dialysis |
0 |
0.08 |
| Hemodynamics |
0 |
0.08 |
| Ischemia |
0 |
0.08 |
| Match |
0 |
0.08 |
| V-Series Nerve Agent |
0 |
0.08 |
| Abdominal Pain |
0 |
0.06 |
| ACE Inhibitor |
0 |
0.05 |
| Angiography |
0 |
0.05 |
| Financial Reimbursement |
0 |
0.05 |
| Impairment |
0 |
0.05 |
| Medicare |
0 |
0.05 |
| Nephrotoxicity |
0 |
0.05 |
| Pain |
0 |
0.05 |
| Abdomen |
0 |
0.03 |
| Atherosclerosis |
0 |
0.03 |
| Clinical Guidelines |
0 |
0.03 |
| Erectile Dysfunction |
0 |
0.03 |
| Food and Drug Administration (FDA) |
0 |
0.03 |
| Generics |
0 |
0.03 |
| Health Policy |
0 |
0.03 |
| Inpatient Care |
0 |
0.03 |
| laparotomy |
0 |
0.03 |
| Lipids Management |
0 |
0.03 |
| Meta-Analysis |
0 |
0.03 |
| Minnesota |
0 |
0.03 |
| Pathogenesis |
0 |
0.03 |
| Plasma |
0 |
0.03 |
| Thrombosis |
0 |
0.03 |
| Tissue |
0 |
0.03 |